Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2018-02-27 Annual Report
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM 10-K
Annual Report FY 2017
2018-02-27 English
FORM 8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 27, 2018. It includes an announcement of the company's financial results for the three months and year ended December 31, 2017, but the results are provided via a press release attached as an exhibit, not as the full report itself. The document also announces a management change, specifically the appointment of a new President - Global Franchises, with detailed compensation information. The presence of Item 5.02 (Departure/Election of Directors or Officers) and detailed compensation terms indicates this is primarily a management change announcement. The financial results announcement is secondary and provided by reference to a press release, not a full earnings release or report. Therefore, the primary classification is Board/Management Information (MANG). The document length (6090 characters) supports it being a full Form 8-K with substantive content, not just a brief announcement. Confidence is high given the clear management appointment and compensation details.
2018-02-27 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-14 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-09 English
SCHEDULE 13G
Major Shareholding Notification
2018-02-09 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-01-19 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.